摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3R,4S,5R)-trimethyl 5-(4-methoxyphenyl)pyrrolidine-2,3,4-tricarboxylate

中文名称
——
中文别名
——
英文名称
(2S,3R,4S,5R)-trimethyl 5-(4-methoxyphenyl)pyrrolidine-2,3,4-tricarboxylate
英文别名
trimethyl (2S,3R,4S,5R)-5-(4-methoxyphenyl)pyrrolidine-2,3,4-tricarboxylate;(2S,3R,4S,5R)-2,3,4-tri(carbomethoxy)-5-(4-methoxyphenyl)pyrrolidine;(2S,3R,4R,5R)-2,3,4-tricarbomethoxy-5-(4-methoxyphenyl)pyrrolidine;(2S,3R,4S,5R)-2,3,4-tricarbomethoxy-5-(4-methoxyphenyl)pyrrolidine;trimethyl 5-(4-methoxyphenyl)pyrrolidine-2,3,4-tricarboxylate
(2S,3R,4S,5R)-trimethyl 5-(4-methoxyphenyl)pyrrolidine-2,3,4-tricarboxylate化学式
CAS
——
化学式
C17H21NO7
mdl
——
分子量
351.356
InChiKey
LULKGQUUVWSKHX-CRWXNKLISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    25
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    100
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    (2S,5R,6S,8R,9R)-5,6-diphenyl-7(R)-(p-methoxyphenyl)-8,9-dicarbomethoxy-1-aza-4-oxabicyclo<4.3.0>nonan-3-one 在 lead(IV) acetate盐酸 作用下, 反应 2.17h, 生成 (2S,3R,4S,5R)-trimethyl 5-(4-methoxyphenyl)pyrrolidine-2,3,4-tricarboxylate
    参考文献:
    名称:
    Asymmetric [1,3]-dipolar cycloaddition reactions: synthesis of highly substituted proline derivatives
    摘要:
    The asymmetric [1,3]-dipolar cycloaddition reactions of azomethine ylides derived from (5R,6S)-2,3,5,6-tetrahydro-5,6-diphenyl-1,4-oxazin-2-one with various aldehydes and dimethyl maleate is described. The reactions prove to be highly endo-selective, installing three contiguous stereogenic centers in the newly formed five-membered ring with essentially complete stereochemical control. In the case of aldehydes higher than formaldehyde, a fourth stereogenic center is created; in most cases, poor stereoselectivity is observed at this center; the diastereomers formed in these cases can be separated by chromatography and separately converted into the amino acids. The bicyclic dipolar adducts can be cleaved with either catalytic hydrogenolysis or hydrolytic ring opening, esterification, and lead tetraacetate removal of the chiral auxiliary.
    DOI:
    10.1021/jo00050a029
点击查看最新优质反应信息

文献信息

  • Bifunctional AgOAc-Catalyzed Asymmetric [3 + 2] Cycloaddition of Azomethine Ylides
    作者:Wei Zeng、Yong-Gui Zhou
    DOI:10.1021/ol0520370
    日期:2005.10.1
    [reaction: see text] A bifunctional AgOAc-catalyzed asymmetric cycloaddition of azomethine ylides with electronic-deficient alkenes was developed using ferrocenyloxazoline-derived N,P ligands. The reactive metal-bound azomethine ylide dipole is formed by the deprotonation with acetate, and extra base is not necessary. The reactions proceed with high enantioselectivity. This method provides an efficient
    [反应:见正文]使用二茂铁基恶唑啉衍生的N,P配体开发了双官能AgOAc催化的偶氮甲亚胺与电子缺陷烯烃的不对称环加成反应。通过与乙酸盐的去质子化反应,与反应性金属结合的偶氮甲碱叶立德偶极子形成,并且不需要额外的碱。反应以高对映选择性进行。该方法提供了制备旋光吡咯烷衍生物的有效且方便的途径。
  • Chiral ferrocenyl P,S-ligands for highly efficient copper-catalyzed asymmetric [3+2] cycloaddition of azomethine ylides
    作者:Fu-Zhong Han、Sai-Bo Yu、Cheng Zhang、Xiang-Ping Hu
    DOI:10.1016/j.tet.2015.01.003
    日期:2016.5
    on benzimidazole and imidazole backbones have been prepared from Ugi's amine through a three-step transformation. These ligands were successfully employed in the Cu-catalyzed asymmetric [3+2] cycloaddition of azomethine ylides with various electron-deficient olefins, giving the corresponding cycloadducts in high endo-selectivities and excellent enantioselectivities (up to 99% ee).
    通过三步转化,由乌吉的胺制备了一系列基于苯并咪唑和咪唑骨架的手性二茂铁基P,S-配体。这些配体已成功地用于铜催化的偶氮甲亚胺与各种缺电子的烯烃的不对称[3 + 2]环加成中,从而以较高的内选择性和出色的对映选择性(高达99%ee)得到相应的环加合物。
  • AgOAc catalyzed asymmetric [3+2] cycloaddition of azomethine ylides with chiral ferrocene derived P,S ligands
    作者:Wei Zeng、Yong-Gui Zhou
    DOI:10.1016/j.tetlet.2007.04.101
    日期:2007.6
    Ferrocene derived P,S-heterodonor ligands were effectively used in AgOAc catalyzed asymmetric cycloaddition of azomethine ylides. The roles of planar chirality and electronic properties of the phosphorous substituents have been examined, and up to 93% ee was obtained.
    二茂铁衍生的P,S-杂配体配体可有效地用于AgOAc催化的甲亚胺基团的不对称环加成反应。已经检查了磷取代基的平面手性和电子性质的作用,并且获得了高达93%的ee。
  • Asymmetric [3+2] Cycloaddition of Azomethine Ylides Catalyzed by Silver(I) Triflate with a Chiral Bipyrrolidine-Derived Phosphine Ligand
    作者:Zhen-Jiang Xu、Chi-Ming Che、Xin Gu、Vanessa Lo
    DOI:10.1055/s-0032-1316779
    日期:——
    bipyrrolidine-derived phosphine ligands L1 and L2 were synthesized. The ‘AgOTf + L1’ protocol catalyzes the asymmetric [3+2] cycloaddition of azomethine ylides with alkenes to give highly substituted pyrrolidines in good yields (up to 90%) with moderate to high diastereoselectivities (up to >19:1 dr) and enantioselectivities (up to 76%). Two novel chiral bipyrrolidine-derived phosphine ligands L1 and L2 were synthesized
    摘要 合成了两个新颖的手性联吡咯烷衍生的膦配体L1和L2。“ AgOTf + L1 ”方案可催化偶氮甲亚胺与烯烃的不对称[3 + 2]环加成反应,以高收率(高达90%),中等至高非对映选择性(高达> 19:1 dr)提供高度取代的吡咯烷。对映选择性(高达76%)。 合成了两个新颖的手性联吡咯烷衍生的膦配体L1和L2。“ AgOTf + L1 ”方案可催化偶氮甲亚胺与烯烃的不对称[3 + 2]环加成反应,以高收率(高达90%),中等至高非对映选择性(高达> 19:1 dr)提供高度取代的吡咯烷。对映选择性(高达76%)。
  • Hydrogen-Bonding Directed Reversal of Enantioselectivity
    作者:Wei Zeng、Guo-Ying Chen、Yong-Gui Zhou、Yu-Xue Li
    DOI:10.1021/ja067346f
    日期:2007.1.1
    successful stereochemical reversal was achieved in AgOAc catalyzed [3+2] cycloaddition by the formation of hydrogen bonding between ligand and reactant. This strategy provides an efficient and convenient route to prepare both enantiomers of a chiral compound. DFT studies proposed a reasonable mechanism of the reversal of the enantioselectivity; hydrogen bonding changed the transition state. The strategy
    通过在配体和反应物之间形成氢键,在 AgOAc 催化的 [3+2] 环加成反应中实现了成功的立体化学逆转。该策略提供了一种有效且方便的途径来制备手性化合物的两种对映异构体。DFT 研究提出了对映选择性逆转的合理机制;氢键改变了过渡态。该策略可为配体设计提供一些有用的提示。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物